1 in 10 Americans over 65 have Alzheimer’s — and this number is even higher in Black Americans

Credit: ThirdSector
Credit: ThirdSector

One in 10 Americans over 65 had dementia, while 22% experienced mild cognitive impairment, the earliest stage of the slow slide into senility, according to a new study conducted between 2016 and 2017.

The research, which the authors said is the first nationally representative examination of cognitive impairment prevalence in more than 20 years, was able to measure prevalence of dementia and mild cognitive impairment by age, education, ethnicity, gender and race.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

Fifteen percent of people who identified as Black tested positive for dementia, while 22% had mild cognitive decline, the study found. Ten percent of people who identified as Hispanic had dementia, but the rate of milder issues was higher — 28% tested positive for mild cognitive impairment. Nine percent of White people had dementia, while 21% had mild cognitive impairment.

Educational achievement, which experts consider to be protective against cognitive decline, showed a significant divide: Nine percent of people with a college degree tested positive for dementia, compared with 13% of those who never received a high school diploma. Twenty-one percent of people over 65 with college degrees had mild cognitive decline, compared with 30% of those with less than a high school degree.

The extreme elderly had the highest rates of dementia and mild cognitive impairment. Only 3% of adults between 65 and 69 tested positive for dementia, compared with 35% of those 90 and older.

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Crumbling MAHA Stage Portrait
Cataloging the RFK Jr.-MAHA crushing midterm collapse
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Blue Checklist in Centered Hand
Viewpoint: From Medicaid cuts to MAHA-backed anti-vaccine and chemical hysteria, voters reject Republicans’ science-skeptical agenda
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Hipster eugenics: better babies for billionaires
Viewpoint: “Positive eugenics”: Reviving a movement reviled and condemned for a century
Reaching Through the Woven Sky
Challenging genetic modification rejectionists: Our evolving food system has relied on science for thousands of years
Picture1
Viewpoint: How badly is the U.S. food-safety net fraying? FDA’s bungled handling of the tainted lettuce crisis deepens concerns over cuts to disease tracking and response
Screenshot 2026-11-04 at 12.02
Ever wonder why AI can so easily be duped into manufacturing health misinformation?    
Bayer Crop Circle in Golden Wheat
Making fertilizer from thin air: Bayer’s gene-editing innovation could dramatically cut chemical fertilizer use in growing food
Smiling-Woman-Over-Teal-Abstract-Shapes
Viewpoint: RFK Jr.’s latest foray into junk science: Even Kennedy’s hand-picked NIH director balks at appointment of crackpot mental health director
Screenshot-2026-10-29-at-11.18.34-AM
Viewpoint: ‘Just the flu’: Skipping your child’s flu shot could be a fatal mistake
Screenshot-2026-11-02-at-11.34.28-AM
Farmers are collateral damage in the PFAS “forever chemicals” crossfire. Here’s what they need to know.
Neon Genome_ Fetal Dreamscape
The race to genetically engineer babies
Screenshot-2026-10-28-at-3.00.44-PM
Viewpoint: Activist attacks on corporations increasingly depend on "attribution" science to target oil companies for global climate change
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.